c1ccc(COC[C@H]2C3OCC([C@H](OCc4ccccc4)[C@H]3OCc3ccccc3)N2Cc2ccccc2)cc1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?